Formic Acid

Formic Acid

SCHEMBL7305919

O=C(N1CCNCC1)N1CCOCC1.O=CO

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.53
CHKA P35790 1/20 0.53
MEN1 O00255 1/20 0.53
TP53 P04637 1/20 0.53
KMT2A Q03164 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 1/20 0.46
RECQL P46063 1/20 0.43
AKR1C3 P42330 4/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
POLB P06746 1/20 0.42
TSHR P16473 1/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA9 Q16790 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL388370 0.92 CA2 (0.61) CA2CHKAMEN1TP53KMT2A
Hydrochloric Acid SCHEMBL1597363 0.90 CA2 (0.59) CA2CHKAMEN1TP53KMT2A
SCHEMBL3074616 0.85 CA2 (0.64) CA2CHKAMEN1TP53KMT2A
Hydrochloric Acid SCHEMBL6762954 0.83 CA2 (0.62) CA2CHKAMEN1TP53KMT2A
Tert-Butyl Formate SCHEMBL27681802 0.81 SMN1; SMN2 (0.44) CA2CHKAMEN1TP53KMT2A
Trifluoroacetic Acid SCHEMBL9066267 0.80 CA2 (0.48) CA2CHKAMEN1TP53KMT2A
SCHEMBL10650643 0.79 CA12 (0.46) CA2CHKAMEN1TP53KMT2A
SCHEMBL2899860 0.78 MEN1 (0.80) MEN1TP53KMT2ASMN1; SMN2MAPT
SCHEMBL2561632 0.78 CA2 (0.80) CA2CHKAMEN1TP53KMT2A
SCHEMBL10665698 0.76 CA2 (0.76) CA2CHKAMEN1TP53KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed